Bridgeway Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$19.8M |
| 2 |
Colgate-Palmolive
CL
|
+$18.1M |
| 3 |
Fox Class A
FOXA
|
+$17.4M |
| 4 |
WRK
WestRock Company
WRK
|
+$17M |
| 5 |
Rollins
ROL
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$27.9M |
| 2 |
Amgen
AMGN
|
+$25.5M |
| 3 |
Pfizer
PFE
|
+$24.6M |
| 4 |
Waste Management
WM
|
+$23.8M |
| 5 |
Sun Communities
SUI
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.79% |
| 2 | Technology | 12.1% |
| 3 | Industrials | 11.16% |
| 4 | Healthcare | 10.96% |
| 5 | Consumer Discretionary | 10.85% |
Similar funds
Bridgeway Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Bridgeway Capital Management held 1,405 positions worth $4.73B, up 8.5% from $4.36B the previous quarter. Its ten largest holdings account for 7% of the portfolio.
Bridgeway Capital Management withdrew a net $511M in Q4 2020, closing 102 positions and reducing 417 holdings. Its most notable exit was Micron Technology, an estimated $27.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
Against the trend, Bridgeway Capital Management opened a new position in Abbott worth $19.9M.
- Bridgeway Capital Management's largest Q4 2020 buy was Abbott: 182,150 shares worth $19.9M.
- Bridgeway Capital Management added most to Rollins in Q4 2020, an estimated $17M increase.
- Bridgeway Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $24.6M.
- Bridgeway Capital Management fully exited Micron Technology in Q4 2020, selling an estimated $27.9M.
- Bridgeway Capital Management's ten largest holdings make up 7% of its $4.73B portfolio in Q4 2020.
- Bridgeway Capital Management opened 92 new positions and closed 102 in Q4 2020.
- Bridgeway Capital Management's portfolio value rose 8.5% quarter-over-quarter to $4.73B.
Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.